Averion

Averion Announces Merger

A Global Biopharmaceutical Development Service Organization Is Formed From Four Portfolio Companies: Averion International, Trio Clinical Research, Fulcrum Pharma and ClinResearch/ADDPLAN.  Learn More. 

 

Therapeutic Expertise

Cardiovascular

Central Nervous System (CNS) Expertise

Averion has conducted many CNS trials in recent years.   We have experience in full-service support of these trials, with particular specialization in Schizophrenia studies among others.   Our expertise includes the following:

  • Back- mental performance
  • Duchenne Muscular Dystrophy
  • Friedreich's Ataxia (adults & children)
  • Glioma- mental performance
  • Multiple Sclerosis (MS)
  • Opticus Neuropathy
  • Paralysis- Urinary, Bowel & Sexual Function
  • Schizophrenia and Schizo-Affective Disorders 
  • Stroke